Clinical trial
Phase II Trial of Daily Dose of Oral Vaccine Against Atherosclerosis
NCT03042741 is registered in ClinicalTrials.gov with Immunitor LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Trial of Daily Dose of Oral Vaccine Against Atherosclerosis
- Lead sponsor
- Immunitor LLC
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- February 1, 2017
- Completion date
- December 18, 2019
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.